SEROX LIMITED
ActiveKey figures
Like most small UK companies, SEROX LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2025/26Sector comparison
SIC 72110Where the company stands among the 3,991 active companies whose first SIC code is 72110 (Research and experimental development on biotechnology).
- BRACCO HORIZONS LIMITED£526.1m
- TAURX THERAPEUTICS MANAGEMENT LTD.£470.3m
- LABCORP EARLY DEVELOPMENT LABORATORIES LIMITED£317m
- JAZZ PHARMACEUTICALS RESEARCH UK LIMITED£289.2m
- GENOME RESEARCH LIMITED£273.7m
- MODERNA BIOTECH UK LIMITED£236.5m
- CURIA (SCOTLAND) LIMITED£183m
- ASTEX THERAPEUTICS LIMITED£163.6m
- HORIZON DISCOVERY GROUP LIMITED£159.6m
- AMGEN LIMITED£134.4m
Positions are approximate. Figures come from each company's latest accounts; money and employee figures are compared only with companies that filed accounts in pounds for a period ending in the last two and a half years and are not dormant, so those groups are smaller than 3,991. The line on each bar marks the median.
Summary: SEROX LIMITED
What kind of company is it?
SEROX LIMITED is a private limited company registered with Companies House under company number 09462917. It was incorporated on 27 Feb 2015. Its status is active. The registered office is in Witney (OX29). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).
How is the company doing financially?
The latest accounts in the database are for 2025/26 (period ending 31 Mar 2026); the company files small company accounts (filleted). Net assets were −£886,920, down 2,468.7% on the previous year. Cash at bank and in hand was £61,640. The company had an average of 14 employees. Figures are available for 6 financial years (2020/21–2025/26).
How does it compare with similar companies?
Compared with 3,991 active companies whose first SIC code is 72110: By net assets it ranks lower than 91% of them (median £20,978). By total assets it ranks higher than 62% of them (median £125,654). By cash it ranks lower than 58% of them (median £101,976). By number of employees it ranks higher than 91% of them (median 1). It is older than 78% of them (median age 5.4 years).
Has it received government grants?
It is recorded as the recipient of 2 central government grants worth £29.8k, from Department for Science, Innovation and Technology.
Who runs and controls the company?
The company has 3 current directors. One person with significant control is registered.
When are its next filings due?
The next accounts are due by 31 Dec 2027. The next confirmation statement is due by 18 Mar 2027.
Filed accounts2020/21–2025/26
| 2021/22 | 2022/23 | 2023/24 | 2024/25 | 2025/26 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | 49,358 | 1,883,691 | 759,385 | 164,360 | 61,640 |
| Total assets | 283,169 | 2,060,306 | 1,167,735 | 587,895 | 322,158 |
| Total liabilities | — | — | — | — | — |
| Net assets / total equity | -89,876 | 1,932,345 | 1,100,990 | 37,444 | -886,920 |
| Average number of employees | 6 | 6 | 11 | 14 | 14 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Government grants
2 grantsSEROX LIMITED is recorded as the recipient of 2 central government grants since 2024, together worth £29.8k.
- Spectroscopic mapping of SERS substrate as part of quality control to ensure diagnostic reliabilityDepartment for Science, Innovation and Technology · £10,150 · UKRI - Innovate UK - Scheme
- Calibration of Raman spectroscopy to allow routine use in clinical environment ("CAL")Department for Science, Innovation and Technology · £19,673 · UKRI - Innovate UK - Scheme
From the Government Grants Register published by the Cabinet Office (financial years 2016/17 onwards, Open Government Licence v3.0). It covers grants from central government departments and their agencies where the register states the recipient's company number and the recipient name matches this company; grants from local authorities, lottery distributors and devolved governments are not included.
History
21 events- Mark Andrew EVANS resignedDirector
- Financial year 2025/26 endedAccounts: net assets −£886.9k, 14 employees
- Financial year 2024/25 endedAccounts: net assets £37.4k, 14 employees
- Name changed to SEROX LIMITEDPreviously VERITIE DIAGNOSTICS LIMITED
- Scott Lewis SHERWOOD appointedDirector
- Name changed to VERITIE DIAGNOSTICS LIMITEDPreviously VERITIE GROUP LIMITED
- Mark Andrew EVANS appointedDirector
- Financial year 2023/24 endedAccounts: net assets £1.1m, 11 employees
Earlier events (13)
- Victoria Janet CLARK appointedSecretary
- Daniel Philip THOMAS resignedDirector
- Financial year 2022/23 endedAccounts: net assets £1.9m, 6 employees
- Cecilia Muldoon ceased to be a person with significant control
- G.B. Trustees Limited registered as a person with significant control
- Name changed to VERITIE GROUP LIMITEDPreviously VERIVIN LIMITED
- Financial year 2021/22 endedAccounts: net assets −£89.9k, 6 employees
- Daniel Philip THOMAS appointedDirector
- Financial year 2020/21 endedAccounts: net assets £98.8k, 7 employees
- Stephen Graham DAVIES appointedDirector
- Cecilia Muldoon registered as a person with significant control
- Cecilia MULDOON appointedDirector
- Company incorporatedPrivate limited company
Dates as recorded at Companies House: incorporation, name changes, officer appointments and resignations, current and former persons with significant control, and the end of each financial year with figures in the database.